Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis.


Journal

Nature cell biology
ISSN: 1476-4679
Titre abrégé: Nat Cell Biol
Pays: England
ID NLM: 100890575

Informations de publication

Date de publication:
11 2019
Historique:
received: 30 05 2019
accepted: 19 09 2019
pubmed: 7 11 2019
medline: 20 2 2020
entrez: 6 11 2019
Statut: ppublish

Résumé

The development of effective therapies against brain metastasis is currently hindered by limitations in our understanding of the molecular mechanisms driving it. Here we define the contributions of tumour-secreted exosomes to brain metastatic colonization and demonstrate that pre-conditioning the brain microenvironment with exosomes from brain metastatic cells enhances cancer cell outgrowth. Proteomic analysis identified cell migration-inducing and hyaluronan-binding protein (CEMIP) as elevated in exosomes from brain metastatic but not lung or bone metastatic cells. CEMIP depletion in tumour cells impaired brain metastasis, disrupting invasion and tumour cell association with the brain vasculature, phenotypes rescued by pre-conditioning the brain microenvironment with CEMIP

Identifiants

pubmed: 31685984
doi: 10.1038/s41556-019-0404-4
pii: 10.1038/s41556-019-0404-4
pmc: PMC7354005
mid: NIHMS1604880
doi:

Substances chimiques

CCL1 protein, human 0
CXCL1 protein, human 0
Chemokine CCL1 0
Chemokine CXCL1 0
Tumor Necrosis Factor-alpha 0
Cyclooxygenase 2 EC 1.14.99.1
PTGS2 protein, human EC 1.14.99.1
CEMIP protein, human EC 3.2.1.35
Hyaluronoglucosaminidase EC 3.2.1.35

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1403-1412

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA169538
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA193461
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA217169
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA232093
Pays : United States

Références

Valastyan, S. & Weinberg, R. A. Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275–292 (2011).
doi: 10.1016/j.cell.2011.09.024
Maher, E. A., Mietz, J., Arteaga, C. L., DePinho, R. A. & Mohla, S. Brain metastasis: opportunities in basic and translational research. Cancer Res. 69, 6015–6020 (2009).
doi: 10.1158/0008-5472.CAN-08-4347
Eichler, A. F. et al. The biology of brain metastases—translation to new therapies. Nat. Rev. Clin. Oncol. 8, 344–356 (2011).
doi: 10.1038/nrclinonc.2011.58
Valiente, M. et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 156, 1002–1016 (2014).
doi: 10.1016/j.cell.2014.01.040
Sevenich, L. et al. Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nat. Cell Biol. 16, 876–888 (2014).
doi: 10.1038/ncb3011
Bos, P. D. et al. Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005–1009 (2009).
doi: 10.1038/nature08021
Lorger, M. & Felding-Habermann, B. Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. Am. J. Pathol. 176, 2958–2971 (2010).
doi: 10.2353/ajpath.2010.090838
Thery, C., Ostrowski, M. & Segura, E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 9, 581–593 (2009).
doi: 10.1038/nri2567
Peinado, H. et al. Pre-metastatic niches: organ-specific homes for metastases. Nat. Rev. Cancer 17, 302–317 (2017).
doi: 10.1038/nrc.2017.6
Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883–891 (2012).
doi: 10.1038/nm.2753
Costa-Silva, B. et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat. Cell Biol. 17, 816–826 (2015).
doi: 10.1038/ncb3169
Hoshino, A. et al. Tumour exosome integrins determine organotropic metastasis. Nature 527, 329–335 (2015).
doi: 10.1038/nature15756
Lowery, F. J. & Yu, D. Brain metastasis: unique challenges and open opportunities. Biochim. Biophys. Acta Rev. Cancer 1867, 49–57 (2017).
doi: 10.1016/j.bbcan.2016.12.001
Polleux, F. & Ghosh, A. The slice overlay assay: a versatile tool to study the influence of extracellular signals on neuronal development. Sci. STKE 2002, pl9 (2002).
pubmed: 12060788
Yoneda, T., Williams, P. J., Hiraga, T., Niewolna, M. & Nishimura, R. A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner. Res. 16, 1486–1495 (2001).
doi: 10.1359/jbmr.2001.16.8.1486
Carbonell, W. S., Ansorge, O., Sibson, N. & Muschel, R. The vascular basement membrane as ‘soil’ in brain metastasis. PLoS One 4, e5857 (2009).
doi: 10.1371/journal.pone.0005857
Lorger, M., Krueger, J. S., O’Neal, M., Staflin, K. & Felding-Habermann, B. Activation of tumor cell integrin α
doi: 10.1073/pnas.0903035106
Abe, S., Usami, S. & Nakamura, Y. Mutations in the gene encoding KIAA1199 protein, an inner-ear protein expressed in Deiters’ cells and the fibrocytes, as the cause of nonsyndromic hearing loss. J. Hum. Genet. 48, 564–570 (2003).
doi: 10.1007/s10038-003-0079-2
Yoshida, H. et al. KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization. Proc. Natl Acad. Sci. USA 110, 5612–5617 (2013).
doi: 10.1073/pnas.1215432110
Evensen, N. A. et al. Unraveling the role of KIAA1199, a novel endoplasmic reticulum protein, in cancer cell migration. J. Natl Cancer Inst. 105, 1402–1416 (2013).
doi: 10.1093/jnci/djt224
Birkenkamp-Demtroder, K. et al. Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells. Br. J. Cancer 105, 552–561 (2011).
doi: 10.1038/bjc.2011.268
Zhang, Y., Jia, S. & Jiang, W. G. KIAA1199 and its biological role in human cancer and cancer cells (review). Oncol. Rep. 31, 1503–1508 (2014).
doi: 10.3892/or.2014.3038
Yang, X. et al. KIAA1199 as a potential diagnostic biomarker of rheumatoid arthritis related to angiogenesis. Arthritis Res. Ther. 17, 140 (2015).
doi: 10.1186/s13075-015-0637-y
Yoshino, Y. et al. Distribution and function of hyaluronan binding protein involved in hyaluronan depolymerization (HYBID, KIAA1199) in the mouse central nervous system. Neuroscience 347, 1–10 (2017).
doi: 10.1016/j.neuroscience.2017.01.049
Zhang, H. et al. Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat. Cell Biol. 20, 332–343 (2018).
doi: 10.1038/s41556-018-0040-4
Winkler, F. Hostile takeover: how tumours hijack pre-existing vascular environments to thrive. J. Pathol. 242, 267–272 (2017).
doi: 10.1002/path.4904
Fidler, I. J. The role of the organ microenvironment in brain metastasis. Semin. Cancer Biol. 21, 107–112 (2011).
doi: 10.1016/j.semcancer.2010.12.009
Arnold, T. & Betsholtz, C. The importance of microglia in the development of the vasculature in the central nervous system. Vasc. Cell 5, 4 (2013).
doi: 10.1186/2045-824X-5-4
Tran, Q. K., Ohashi, K. & Watanabe, H. Calcium signalling in endothelial cells. Cardiovasc. Res. 48, 13–22 (2000).
doi: 10.1016/S0008-6363(00)00172-3
Liebner, S. et al. Wnt/beta-catenin signaling controls development of the blood–brain barrier. J. Cell Biol. 183, 409–417 (2008).
doi: 10.1083/jcb.200806024
Shimizu, H. et al. Hyaluronan-binding protein involved in hyaluronan depolymerization is up-regulated and involved in hyaluronan degradation in human osteoarthritic cartilage. Am. J. Pathol. 188, 2109–2119 (2018).
doi: 10.1016/j.ajpath.2018.05.012
Burri, P. H., Hlushchuk, R. & Djonov, V. Intussusceptive angiogenesis: its emergence, its characteristics, and its significance. Dev. Dyn. 231, 474–488 (2004).
doi: 10.1002/dvdy.20184
Dimova, I. et al. Inhibition of Notch signaling induces extensive intussusceptive neo-angiogenesis by recruitment of mononuclear cells. Angiogenesis 16, 921–937 (2013).
doi: 10.1007/s10456-013-9366-5
Giacomini, A. et al. Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease. Angiogenesis 18, 499–510 (2015).
doi: 10.1007/s10456-015-9481-6
Doron, H., Pukrop, T. & Erez, N. A blazing landscape: neuroinflammation shapes brain metastasis. Cancer Res. 79, 423–436 (2019).
doi: 10.1158/0008-5472.CAN-18-1805
Tominaga, N. et al. Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood–brain barrier. Nat. Commun. 6, 6716 (2015).
doi: 10.1038/ncomms7716
van der Vos, K. E. et al. Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain. Neuro Oncol. 18, 58–69 (2016).
doi: 10.1093/neuonc/nov244

Auteurs

Gonçalo Rodrigues (G)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Graduate Program in Areas of Basic and Applied Biology, Abel Salazar Biomedical Sciences Institute, University of Porto, Porto, Portugal.

Ayuko Hoshino (A)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo, Tokyo, Japan.
JST, PRESTO, Tokyo, Japan.

Candia M Kenific (CM)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Irina R Matei (IR)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Loïc Steiner (L)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.

Daniela Freitas (D)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
i3S-Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.
Instituto de Ciências Biomédicas Abel Salazar (ICBAS), University of Porto, Porto, Portugal.

Han Sang Kim (HS)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Yonsei Cancer Center, Division of Medical Oncology, Departments of Internal Medicine, and Pharmacology, Yonsei University College of Medicine, Seoul, Korea.

Peter R Oxley (PR)

Samuel J. Wood Library, Weill Cornell Medicine, New York, NY, USA.

Ilana Scandariato (I)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Irene Casanova-Salas (I)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Jinxiang Dai (J)

Public Health Sciences Division/Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Chaitanya R Badwe (CR)

Ansary Stem Cell Institute, Division of Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Brunilde Gril (B)

Woman's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Milica Tešić Mark (M)

Proteomics Resource Center, The Rockefeller University, New York, NY, USA.

Brian D Dill (BD)

Proteomics Resource Center, The Rockefeller University, New York, NY, USA.

Henrik Molina (H)

Proteomics Resource Center, The Rockefeller University, New York, NY, USA.

Haiying Zhang (H)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Alberto Benito-Martin (A)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Linda Bojmar (L)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Yonathan Ararso (Y)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Katharine Offer (K)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Quincey LaPlant (Q)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Weston Buehring (W)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Huajuan Wang (H)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Xinran Jiang (X)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.

Tyler M Lu (TM)

Ansary Stem Cell Institute, Division of Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine and Infertility, Weill Cornell Medicine (WCM), New York, NY, USA.

Yuan Liu (Y)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Joshua K Sabari (JK)

Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Sandra J Shin (SJ)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.

Navneet Narula (N)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.

Paula S Ginter (PS)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.

Vinagolu K Rajasekhar (VK)

Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Centre, New York, NY, USA.

John H Healey (JH)

Orthopaedic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Etienne Meylan (E)

Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.

Bruno Costa-Silva (B)

Systems Oncology Group, Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal.

Shizhen Emily Wang (SE)

Department of Pathology, University of California, San Diego, La Jolla, CA, USA.

Shahin Rafii (S)

Ansary Stem Cell Institute, Division of Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Nasser Khaled Altorki (NK)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY, USA.

Charles M Rudin (CM)

Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

David R Jones (DR)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Patricia S Steeg (PS)

Woman's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Héctor Peinado (H)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Microenvironment and Metastasis Laboratory, Department of Molecular Oncology, Spanish National Cancer Research Center (CNIO), Madrid, Spain.

Cyrus M Ghajar (CM)

Public Health Sciences Division/Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Jacqueline Bromberg (J)

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Department of Medicine, Weill Cornell Medicine, New York, NY, USA.

Maria de Sousa (M)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. mdesousa@ibmc.up.pt.
Graduate Program in Areas of Basic and Applied Biology, Abel Salazar Biomedical Sciences Institute, University of Porto, Porto, Portugal. mdesousa@ibmc.up.pt.

David Pisapia (D)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA. djp2002@med.cornell.edu.

David Lyden (D)

Children's Cancer and Blood Foundation Laboratories, Departments of Pediatrics, and Cell and Developmental Biology, Drukier Institute for Children's Health, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA. dcl2001@med.cornell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH